ArticleMolecular therapy. Oncology2026

Targeting the tumor, harboring the host: IL-7 receptor-targeted CARs to treat T-ALL.

Valeriya Kuznetsova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.